Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a named patient programme at a single UK center

2.50
Hdl Handle:
http://hdl.handle.net/10541/297412
Title:
Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a named patient programme at a single UK center
Authors:
Gibb, Adam; Jones, Craig; Bloor, Adrian; Kulkarni, Samar; Illidge, Timothy M ( 0000-0003-3191-7324 ) ; Linton, Kim M ( 0000-0002-3294-1548 ) ; Radford, John A ( 0000-0001-7898-2786 )
Affiliation:
The Christie NHS Foundation Trust, Wilmslow Road, Withington, Manchester, M20 9BX, UK
Citation:
Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a named patient programme at a single UK center 2012, 98 (4):611 Haematologica
Journal:
Haematologica
Issue Date:
2013
URI:
http://hdl.handle.net/10541/297412
DOI:
10.3324/haematol.2012.069393
Additional Links:
http://www.haematologica.org/cgi/doi/10.3324/haematol.2012.069393
Type:
Article
Language:
en
ISSN:
0390-6078; 1592-8721
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorGibb, Adamen_GB
dc.contributor.authorJones, Craigen_GB
dc.contributor.authorBloor, Adrianen_GB
dc.contributor.authorKulkarni, Samaren_GB
dc.contributor.authorIllidge, Timothy Men_GB
dc.contributor.authorLinton, Kim Men_GB
dc.contributor.authorRadford, John Aen_GB
dc.date.accessioned2013-08-05T13:34:49Z-
dc.date.available2013-08-05T13:34:49Z-
dc.date.issued2013-
dc.identifier.citationBrentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a named patient programme at a single UK center 2012, 98 (4):611 Haematologicaen_GB
dc.identifier.issn0390-6078-
dc.identifier.issn1592-8721-
dc.identifier.doi10.3324/haematol.2012.069393-
dc.identifier.urihttp://hdl.handle.net/10541/297412-
dc.language.isoenen
dc.relation.urlhttp://www.haematologica.org/cgi/doi/10.3324/haematol.2012.069393en_GB
dc.rightsArchived with thanks to Haematologicaen_GB
dc.titleBrentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a named patient programme at a single UK centeren
dc.typeArticleen
dc.contributor.departmentThe Christie NHS Foundation Trust, Wilmslow Road, Withington, Manchester, M20 9BX, UKen_GB
dc.identifier.journalHaematologicaen_GB
All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.